News & Articles

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The drug aims to treat patients with myelodysplastic syndromes

Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers

Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment

The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients

LGC has been working with NHS Test and Trace to support the UK's response to the pandemic

VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies

Take lateral flow diagnostics to the next level with improved sensitivity for the future of IVDs

Gain insights into topics ranging from food and beverage testing to lab sustainability, Raman microscopy and seasonal viruses

Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity

Collaboration aims to provide new workflows, faster acquisition speeds and deeper resolution

Panbio COVID-19 Antigen Self-Test is approved for sale directly to consumers, enabling fast, convenient coronavirus testing

Watch this on-demand webinar to understand the key considerations for selecting culture media products

Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized

Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg

The multi-analyte respiratory panel combines Flu A/B and respiratory syncytial virus (RSV) targets with the SARS-CoV-2 target